Market revenue in 2022 | USD 53.2 million |
Market revenue in 2030 | USD 85.2 million |
Growth rate | 6% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 38.91% in 2022. Horizon Databook has segmented the Germany sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
Sepsis diagnostics is a rapidly growing field in Germany, with several companies and organizations competing in the market to develop and sell diagnostic tests for sepsis.
The German Federal Minister of Health Karl Lauterbach and WHO Director-General Tedros Adhanom Ghebreyesus jointly sponsored a World Sepsis Day event in Berlin on September 16, 2022. The 4th World Sepsis Congress, titled "One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance," was held on April 25 and 26, 2023.
This alarming mortality rate is expected to drive the growth of the sepsis diagnostics market in Germany. According to the Fraunhofer Institute for Interfacial Engineering and Biotechnology, sepsis, which results from bloodstream infections, is responsible for approximately 60,000 deaths annually in Germany.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account